Apoptosis is a process of programmed cell death that is traditionally considered to be immunologically silent. This means that it does not trigger an inflammatory response from the immune system. However, a new study has shown that apoptosis can actually provoke inflammation in zebrafish and cell culture when apoptotic epithelial cells cannot be expelled from the monolayer by apical extrusion. This is due to an intrinsic circuit where ATP released from apoptotic cells stimulates epithelial cells in the immediate vicinity to produce interleukin-8 (IL-8). Apical extrusion therefore prevents inappropriate epithelial inflammation by physically eliminating apoptotic cells before they can activate this pro-inflammatory circuit. This carries the implication that epithelia may be predisposed to inflammation, elicited by sporadic or induced apoptosis, if apical extrusion is compromised.
Related Posts
Lipids: The Key to Understanding Human Physiology and Disease
Lipids are a diverse group of molecules that play essential roles in human physiology and disease. A new study published in Nature Metabolism has taken a deep dive into the human lipidome, tracking how it changes under healthy and diseased conditions. The study found that although everyone’s lipidome has a distinctive signature, certain types of […]
Unveiling Cancer’s Secrets: Abnormal cell division remnants can sow genomic chaos, fueling cancer spread. Research is unraveling this intricate connection to curb cancer’s advance.
Remnants of incomplete or abnormal cell division, such as micronuclei and aneuploidy, could contribute to the spread of cancer. When cells divide incorrectly, they may produce genetic material that is extruded into micronuclei, which can lead to genomic instability. This instability can result in genetic mutations, potentially promoting tumor growth and metastasis. Understanding these processes […]
Genetic Discovery Could Lead to Personalized Treatments for Inflammation
Researchers have discovered a genetic change that increases the risk of inflammation, carried by up to 3% of the global population. This study could lead to better personalized treatments for inflammation and other diseases in the future. Source: – https://www.sciencedaily.com/releases/2023/10/231002184441.htm